TRVI short interest
Trevi Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 14,639,150 |
|---|---|
| Change vs prior report | 2,568,525 (+21.3%) |
| Change over six months | -4.3% |
| Days to cover | 8.33 (sector: 3.78) |
| Average daily volume | 1,756,639 |
| Rank in Healthcare | #184 of 922 by days to cover |
TRVI short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 14,639,150 | +21.3% | 8.33 | 1,756,639 |
| 2026-09-15 | 12,070,625 | +0.5% | 8.79 | 1,373,723 |
| 2026-08-31 | 12,012,371 | -5.1% | 8.04 | 1,494,034 |
| 2026-08-14 | 12,657,630 | -3.7% | 7.83 | 1,617,552 |
| 2026-07-31 | 13,147,012 | +3.9% | 5.40 | 2,434,305 |
| 2026-07-15 | 12,653,483 | -8.8% | 4.76 | 2,659,448 |
| 2026-06-30 | 13,870,118 | -3.4% | 4.00 | 3,465,819 |
| 2026-06-15 | 14,351,654 | +5.7% | 14.77 | 971,606 |
| 2026-05-29 | 13,574,699 | +2.1% | 12.40 | 1,094,911 |
| 2026-05-15 | 13,289,352 | -13.1% | 8.71 | 1,525,091 |
| 2026-04-30 | 15,291,551 | -5.2% | 6.72 | 2,274,244 |
| 2026-04-15 | 16,139,168 | +5.5% | 13.44 | 1,200,702 |
| 2026-03-31 | 15,295,203 | -7.0% | 11.25 | 1,359,486 |
| 2026-03-13 | 16,442,993 | -2.2% | 12.10 | 1,358,462 |
| 2026-02-27 | 16,813,915 | +5.0% | 15.09 | 1,114,052 |
| 2026-02-13 | 16,010,995 | +3.3% | 11.99 | 1,334,825 |
| 2026-01-30 | 15,504,499 | -0.3% | 9.79 | 1,583,339 |
| 2026-01-15 | 15,556,094 | +10.3% | 11.06 | 1,406,785 |
| 2025-12-31 | 14,105,563 | +3.3% | 9.56 | 1,476,215 |
| 2025-12-15 | 13,651,656 | +1.9% | 5.22 | 2,617,433 |
| 2025-11-28 | 13,403,743 | -9.3% | 6.24 | 2,146,416 |
| 2025-11-14 | 14,784,433 | -5.4% | 9.78 | 1,510,980 |
| 2025-10-31 | 15,623,820 | +7.1% | 10.69 | 1,462,214 |
| 2025-10-15 | 14,589,302 | -1.6% | 8.63 | 1,690,473 |
| 2025-09-30 | 14,825,735 | +22.6% | 6.67 | 2,223,238 |
import finzdata as yf
yf.Ticker("TRVI").short_interest # every report since 2017
yf.Client().short_interest(["TRVI"], start="2018-01-01")Healthcare short interest · TRVI price history · Who owns TRVI · All short interest